Atria Investments Inc Cuts Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Atria Investments Inc decreased its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 31.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,302 shares of the company’s stock after selling 9,243 shares during the period. Atria Investments Inc’s holdings in Ryan Specialty were worth $1,303,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of RYAN. Assetmark Inc. bought a new position in Ryan Specialty in the third quarter valued at about $34,000. Principal Securities Inc. lifted its stake in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock worth $43,000 after purchasing an additional 415 shares during the period. Quarry LP boosted its holdings in shares of Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company’s stock worth $54,000 after buying an additional 422 shares during the last quarter. Loomis Sayles & Co. L P boosted its holdings in shares of Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after buying an additional 286 shares during the last quarter. Finally, R Squared Ltd bought a new stake in Ryan Specialty during the fourth quarter valued at approximately $92,000. 84.82% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

RYAN has been the topic of several recent research reports. Barclays lifted their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research report on Friday, February 21st. Morgan Stanley initiated coverage on Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. Royal Bank of Canada decreased their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research note on Friday, February 21st. Finally, Keefe, Bruyette & Woods cut their price objective on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $75.27.

Ryan Specialty Trading Down 0.4 %

Shares of Ryan Specialty stock opened at $68.34 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market cap of $17.89 billion, a price-to-earnings ratio of 99.04, a PEG ratio of 1.19 and a beta of 0.71. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97. The business has a 50-day moving average price of $66.75 and a 200-day moving average price of $67.66.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. Equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date is Tuesday, March 4th. Ryan Specialty’s dividend payout ratio (DPR) is presently 69.57%.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 29,466 shares of the stock in a transaction on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the sale, the director now owns 45,409 shares in the company, valued at $2,954,309.54. This trade represents a 39.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last 90 days, insiders sold 316,451 shares of company stock worth $20,907,793. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.